María José S. A.
- Country
- Spain
- Department
- Oncología Médica
Research Overview
- Phase III Study Comparing FOLFOX Plus Panitumumab Followed by FOLFIRI Plus Bevacizumab Versus FOLFOX Plus Bevacizumab Followed by FOLFIRI Plus Panitumumab in Wild-Type RAS Metastatic Colorectal Cancer
- Sotorasib and Combination Therapy Versus Standard Chemotherapy in Treatment-Naïve Patients with KRAS p.G12C-Mutated Metastatic Colorectal Cancer
- Phase 3 Randomized Study of Perioperative Dostarlimab vs. Standard of Care in Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
Data & Insights
Has run more than one trial at 143 of 339 partner sites.
Specializations
Metastatic Colorectal Cancer
This investigator specializes in treating advanced forms of metastatic colorectal cancer, with particular emphasis on innovative therapeutic combinations. Their expertise extends to managing cases with specific genetic mutations, including BRAF V600E-mutant mCRC and microsatellite stable (MSS) variants.
- Combined immunotherapy approaches
- Targeted therapy combinations
- Molecular-guided treatment strategies
Precision Oncology
The investigator focuses on developing personalized treatment approaches in colorectal cancer care. Their work incorporates genetic vaccination strategies and molecular biomarker analysis, particularly in microsatellite instability high (MSI-H) tumors.
- Genetic-based targeted treatments
- Immunotherapy optimization
- Biomarker-driven therapy selection
Early-Stage Disease Management
The investigator conducts research in perioperative treatment strategies for early-stage colorectal cancer. Their work includes studying circulating tumor DNA (ctDNA) guided approaches and novel interventions for stage II and III colon cancer.
- Personalized post-surgical care
- Risk-adapted treatment selection
- Advanced diagnostic monitoring
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.